Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Research on its long-term safety remains insufficient
Multi-route: After reconstitution, the resulting mixture can be administered IV, IM, or SC per the drugs instructions
May support healing of muscle tears and connective tissue damage after intense lifting or endurance events
Athira went public in September 2020 on the strength of the mechanism, raising 204 million dollars
Nasal administration provides a convenient, non-invasive option, making it ideal for individuals focused on faster recovery, injury support, and long-term resilience
This approach would allow cell therapy for stroke to progress from empiric transplantation toward mechanism-guided regenerative pharmacology
US$ 23.73
US$ 23.88
US$ 25.14
